![](https://cerbaresearch.com/app/uploads/2022/09/shutterstock_1658285683-scaled.jpg)
Poster – Novel Image Analysis And IHC Advances For NASH
Global prevalence of non-alcoholic fatty liver disease (NAFLD) is 25.24% in 2016,…
Read more
![Cerba Research US - Flow Cytometry Cytek Aurora](https://cerbaresearch.com/app/uploads/2023/01/DSC00192-scaled.jpg)
Webinar – Cytek Aurora Instrument Standardization For Patient Testing In Global Clinical Trials
Recently Cerba Research’s Regional Head of Flow Cytometry, Veronica Nash, PhD, presented…
Read more
![](https://cerbaresearch.com/app/uploads/2022/10/White-Paper-Precision-Medicing-for-Non-Small-Cell-Lung-Cancer-NSCLC-short.jpg)
White Paper – Precision Medicine For Non-Small Cell Lung Cancer (NSCLC) – Emerging Trends In Molecular Analysis
Of all types of cancer, lung cancer caused more deaths worldwide than…
Read more
![](https://cerbaresearch.com/app/uploads/2023/02/DSC09943-scaled.jpg)
Poster – CYTO 2023 Poster Pack
Comparison of BD FACSLyric™ Instrument Performance in a Global Setting As flow…
Read more
![](https://cerbaresearch.com/app/uploads/2023/06/Certificat-EN-pdf.jpg)
Cerba Xpert – ISO 9001:2015
Read more
![Cerba Research - Certificate - Decision CIR Cerba Xpert_](https://cerbaresearch.com/app/uploads/2023/02/Cerba-Research-Certificate-Decision-CIR-Cerba-Xpert_.jpg)
Agrément CIR – Cerba Xpert
Expenses incurred by a company in research or innovation operations, entrusted to…
Read more
![](https://cerbaresearch.com/app/uploads/2023/02/Agrement-CIR-2021-2025.jpg)
Agrément CIR – Histalim
Expenses incurred by a company in research or innovation operations, entrusted to…
Read more
![](https://cerbaresearch.com/app/uploads/2022/08/11.jpg)
Presentation – Automatization Of Immunohistochemistry Data Analysis For Protocol Validation
This presentation was given by Marie Gerus-Durand, Principal Scientist & Validation Engineer…
Read more
![](https://cerbaresearch.com/app/uploads/2022/09/shutterstock_1658285683-scaled.jpg)
Case Study – A Blood-based Biomarker Panel For Non-invasive Diagnosis Of Non-alcoholic Steatohepatitis: A Multi-centre Prospective And Validation Study
A late-stage biopharmaceutical company dedicated to metabolic and chronic liver diseases is…
Read more
![](https://cerbaresearch.com/app/themes/cerba/resources/assets/images/cerba-logo--fullsize.png)
Publication – Dynamics Of Circulating Calprotectin Accurately Predict The Outcome Of Moderate COVID-19 Patients
Discover how circulating calprotectin measurement could be a predictor of moderate COVID-19…
Read more
![Cerba US Expansion Tour VF.00_04_27_19.Still010](https://cerbaresearch.com/app/uploads/2022/07/Cerba-US-Expansion-Tour-VF.00_04_27_19.Still010.jpg)
Together, we can shape the future of your clinical development. Find out more about how we can support your research.
Contact Us